Bristol Myers Squibb’s Abecma recommended for EU approval

The EMA CHMP has recommended marketing authorisation for Bristol Myers Squibb’s Abecma for multiple myeloma.

Jan 29, 2024 - 18:00

Bristol Myers Squibb’s Abecma recommended for EU approval

The EMA CHMP has recommended marketing authorisation for Bristol Myers Squibb’s Abecma for multiple myeloma.

Read the original article

Tags:

Previous Article

Celltrion USA seeks FDA approval for CT-P47 biosimilar

‘Seismic shift’ to crowdsourced scientific data presents promising, complex oppo...

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

FDA rejects Aldeyra’s dry eye drug, asks for more clinical data

FDA rejects Aldeyra’s dry eye drug, asks for more clini...

Nov 28, 2023

As England’s virus hospitalisations surge flu vaccines evolve

As England’s virus hospitalisations surge flu vaccines ...

Feb 2, 2024

Flu vaccine strategy on the line as new US leaders anticipated to take charge

Flu vaccine strategy on the line as new US leaders anti...

Dec 13, 2024